Picture1.png
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
20 juin 2023 08h01 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer...
Picture1.png
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
02 mai 2023 17h01 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Picture1.png
Harvard Bioscience Announces First Quarter 2023 Financial Results
25 avr. 2023 08h01 HE | Harvard Bioscience, Inc.
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4...
Picture1.png
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
18 avr. 2023 17h10 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral...
Picture1.png
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
17 avr. 2023 16h45 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April...
Picture1.png
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
16 mars 2023 17h14 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Picture1.png
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
16 mars 2023 09h25 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Picture1.png
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
09 mars 2023 07h00 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31,...
Picture1.png
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET 
28 févr. 2023 16h10 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on...
Picture1.png
Harvard Bioscience Announces CFO Transition
12 déc. 2022 08h30 HE | Harvard Bioscience, Inc.
HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer...